ResearcherGeorgetown University Medical CenterNo recent work listed

Weiying Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2793-2233; OpenAlex author ID A5101559179. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper

Papers 1

Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Co-author DOI 10.1126/scisignal.2005049 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eveline E. Vietsch · 1 shared paper, 2014 · strength 0.03
- Paper Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal… DOI 10.1126/scisignal.2005049 ↗
Jeffrey A Toretsky · 1 shared paper, 2014 · strength 0.03
- Paper Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal… DOI 10.1126/scisignal.2005049 ↗
Anton Wellstein · 1 shared paper, 2014 · strength 0.03
- Paper Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal… DOI 10.1126/scisignal.2005049 ↗
Chunling Yi · 1 shared paper, 2014 · strength 0.03
- Paper Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal… DOI 10.1126/scisignal.2005049 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.